Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Quintiles Expands Access for Indonesia Trials | Contract Pharma

What are you searching for?

Sign in
Breaking News

Quintiles Expands Access for Indonesia Trials

Partners with Prodia to test trial samples

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Quintiles began its first global study involving Indonesia, through an exclusive alliance with Prodia Clinical Laboratory to provide in-country testing of samples from Indonesian patients in clinical trials. Indonesia has previously been difficult to include in global trials because of requirements that all local samples be tested in-country before data can be exported. The alliance with Prodia allows Quintiles to test trial samples.

“We have embarked on a new chapter for clinical research in Indonesia with the placement of our first study there using Prodia’s CAP-accredited harmonized central laboratory,” said Alan Ong, vice president and general manager of Quintiles Southeast Asia. “Indonesia is now part of a diabetes study that’s expected to enroll about 14,000 patients globally. This is testament to Quintiles’ commitment to obtain evidence of the potential benefits of new medicines in patient populations for whom they are intended.”

In November 2011, Quintiles partnered with Jakarta-based Prodia Clinical Laboratory through its sister company Prodia CRO, giving Quintiles access to Prodia’s central lab for a two-year period.

Endang Hoyaranda, president director of Prodia Group, said, “Prodia is proud to partner with Quintiles in establishing Indonesia as a regional hub for clinical trials. As the local market leader and only CAP-accredited central laboratory in Indonesia, Prodia is playing a significant role in helping establish Indonesia as a clinical trial center of excellence.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics